The development of ischemic brain damage is dramatically affected by the immune system,whose activation occurs immediately after the insult and may last for several days,involving a complex interplay between soluble a...The development of ischemic brain damage is dramatically affected by the immune system,whose activation occurs immediately after the insult and may last for several days,involving a complex interplay between soluble and cellular mediators（Amantea et al.,2015）.Accordingly,recent expression profiling studies have revealed that the majority of the genes modulated in the blood of stroke patients participate in the regulation of innate immune responses（Brooks et al.,2014）.展开更多
Emerging single-cell technologies create new opportunities for unraveling tumor heterogeneity.However,the development of high-content phenotyping platform is still at its infancy.Here,we develop a microfluidic chip fo...Emerging single-cell technologies create new opportunities for unraveling tumor heterogeneity.However,the development of high-content phenotyping platform is still at its infancy.Here,we develop a microfluidic chip for two-dimensional(2D)profiling of tumor chemotactic and molecular features at single cell resolution.Individual cells were captured by the triangular micropillar arrays in the cell-loading channel,facilitating downstream single-cell analysis.For 2D phenotyping,the chemotactic properties of tumor cells were visualized through cellular migratory behavior in microchannels,while their protein expression was profiled with multiplex surface enhanced Raman scattering(SERS)nanovectors,in which Raman reporter-embedded gold@silver core-shell nanoparticles(Au@Ag REPs)were modified with DNA aptamers targeting cellular surface proteins.As a proof of concept,breast cancer cells with diverse phenotypes were tested on the chip,demonstrating the capability of this platform for simultaneous chemotactic and molecular analysis.The chip is expected to provide a powerful tool for investigating tumor heterogeneity and promoting clinical precision medicine.展开更多
文摘The development of ischemic brain damage is dramatically affected by the immune system,whose activation occurs immediately after the insult and may last for several days,involving a complex interplay between soluble and cellular mediators（Amantea et al.,2015）.Accordingly,recent expression profiling studies have revealed that the majority of the genes modulated in the blood of stroke patients participate in the regulation of innate immune responses（Brooks et al.,2014）.
基金This study was supported by the National Science Fund for Excellent Young Scholars(No.61822503)the National Natural Science Foundation of China(Nos.62175030 and 62175027)+3 种基金China Postdoctoral Science Foundation(No.2021TQ0147)Jiangsu Innovation and Entrepreneurship Program(No.JSSCBS20210126)Nanjing Science and Technology Innovation Project for Returned Overseas Chinese Scholars(No.1106000308)the Fundamental Research Funds for the Central Universities(Nos.3206002104D and 3206002108A1).
文摘Emerging single-cell technologies create new opportunities for unraveling tumor heterogeneity.However,the development of high-content phenotyping platform is still at its infancy.Here,we develop a microfluidic chip for two-dimensional(2D)profiling of tumor chemotactic and molecular features at single cell resolution.Individual cells were captured by the triangular micropillar arrays in the cell-loading channel,facilitating downstream single-cell analysis.For 2D phenotyping,the chemotactic properties of tumor cells were visualized through cellular migratory behavior in microchannels,while their protein expression was profiled with multiplex surface enhanced Raman scattering(SERS)nanovectors,in which Raman reporter-embedded gold@silver core-shell nanoparticles(Au@Ag REPs)were modified with DNA aptamers targeting cellular surface proteins.As a proof of concept,breast cancer cells with diverse phenotypes were tested on the chip,demonstrating the capability of this platform for simultaneous chemotactic and molecular analysis.The chip is expected to provide a powerful tool for investigating tumor heterogeneity and promoting clinical precision medicine.
